IP Library Granted Patent US 7,897,559
Granted Patent B2
US 7,897,559 · App. 10/730,783 · Granted Mar 1, 2011

Dermatological composition and kit containing avermectin compound for treating dermatological conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,897,559
App. No.
10/730,783
Granted
Mar 1, 2011
Kind
B2
Abstract

A dermatological composition and a kit containing the composition for treating dermatological conditions including transient acantholytic dermatitis, acne miliaris necrotica, acne varioliformis, perioral dermatitis, acneiform eruptions, acne vulgaris, and seborrheic dermatitis are disclosed. The dermatological composition includes an avermectin compound in an effective amount to treat these dermatological conditions and a pharmaceutically acceptable carrier. The kit includes the dermatological composition integrated in medicated tape, topical dressing, dermal patch, or cleansing tissue.

Claims (6)

1. A dermatological composition for topically treating dermatological conditions comprising transient acantholytic dermatitis, acne miliaris necrotica, acne varioliformis, perioral dermatitis, acneiform eruptions, acne vulgaris, or seborrheic dermatitis, said composition consisting of an avermectin compound in a concentration from 0.05% to 0.1% (w/v) in a lotion consisting of glycerin, hydrogenated polyisobutene, cetearyl alcohol, polyoxyethylene ether of cetyl and stearyl alcohol, macadamia nut oil, dimethicone, tocopheryl acetate, stearoxytrimethylsilane, stearyl alcohol, panthenol, farnesol, benzyl alcohol, phenoxyethanol, acrylates/C10-30 alkyl acrylate crosspolymer, sodium hydroxide, citric acid, and water; said composition not causing skin irritation of patients suffering from said dermatological conditions upon repetitive daily use.

2. The dermatological composition of claim 1 , wherein said avermectin compound comprises avermectin, avermectin derivatives, ivermectin, or ivermectin derivatives.

3. The dermatological composition of claim 2 , wherein said avermectin compound is ivermectin.

4. The dermatological composition of claim 3 , wherein said ivermectin is in a concentration of about 0.075%.

5. The dermatological composition of claim 1 , wherein said composition is effective in treating said dermatological conditions.

6. The dermatological composition of claim 1 , wherein said composition is integrated in one form selected from the group consisting of medicated tape, topical dressing, dermal patch, and cleansing tissue.

Continuity (9)
Continuation In Part 10159938 · Jun 3, 2002
Continuation 09976915 · Oct 12, 2001
Continuation In Part 09605747 · Jun 29, 2000
Continuation In Part 10730783
Continuation In Part 10161585 · Jun 3, 2002
Continuation 09988914 · Nov 19, 2001
Continuation In Part 09976915 · Oct 12, 2001
Continuation In Part 09605747 · Jun 29, 2000
Related Publication 20040167084A1 · Aug 26, 2004